INTERNATIONAL PATENT: HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD., 杭州天龙药业有限公司 FILES APPLICATION FOR "SIRNA FOR REGULATING AGT GENE EXPRESSION AND USE THEREOF"

GENEVA, May 10 -- HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD. (Room 701, Building 3, Yinhai Science And Technology Innovation Center, Xiasha Subdistrict, Qiantang DistrictHangzhou, Zhejiang 310020), 杭州天龙药业有限公司 (中国浙江省杭州市钱塘区下沙街道银海科创中心3幢701室) filed a patent application (PCT/CN2025/131488) for "SIRNA FOR REGULATING AGT GENE EXPRESSION AND USE THEREOF" on Oct 31, 2025. With publication no. WO/2026/092641, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was su...